Livionex, recently announced a successful end-of-Phase 2 meeting with the FDA, supporting the advancement of C-KAD, a 2.6% EDTA ophthalmic solution, to a Phase 3 clinical study. In an interview with ...

Digital axis marking is as effective as a manual approach when implanting toric ICLs for patients with astigmatic myopia.

ICL and parent company Israel Corp. jumped sharply as Energean led the declines. The Tel Aviv Stock Exchange rose today. The Tel Aviv 35 Index rose 0.16% to 2,207.83 points, the Tel Aviv 125 Index ...

STAAR Surgical Company , a leading developer, manufacturer, and marketer of the EVO family of Implantable Collamer® lenses (EVO ICLtm) for myopia, astigmatism and presbyopia, is proud to announce a ...

ICL Group (ICL) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook ...

Operator: Greetings and welcome to the STAAR Surgical Third Quarter 2024 Earnings Webcast. As a reminder, this event is being ...

China sales were up 7% and ICL unit growth was positive ... sustainable growth in this second largest market in refractive surgery around the world. Ryan Zimmerman: Okay. And then just to follow ...

China sales were up 7% and ICL unit growth was positive ... sustainable growth in this second largest market in refractive surgery around the world. Look, Ryan, I appreciate the question of ...

We wrap up our coverage of the markets and the week. We sell different types of products and services to both investment professionals and individual investors. These products and services are ...